All Type of News
Sang-A Pharm seeking to produce generic drugs
Sang-A Pharm said that as part of diversifying its business sector and sales boost, it has recently set up FineChem., a drug synthesis corporation, with a pain-in capital of 500 million won in a bid to meet the increa...
648 expensive drugs to put under major supervision.
Prescriptions for 648 expensive drugs will put under the special checking list and the government will take a special investigation for the medical institutions where these expensive drugs are habitually prescribed.
...
MOHW to legislate administrative measures against false and unfair bills.
The MOHW disclosed the revised draft of the working rules of the pharmaceutical affairs act on June 12 that adjusted and set up the standards for the administrative measures to the pharmacy against false and unfair bi...
Number of medical institution up
Amid protracted pharmaceutical business slowdown, the overall number of medical institutions increased 4.2 percent from 64,166 in May last year to 66,829 in August this years, according to tallies released by ...
Production statistics of drugs, etc. to go public
The Korea Pharmaceutical Manufacturers Association held a board meeting on July 12 at Palace Hotel and decided to re-publish production statistics of drugs, etc. which had been unavailable since the end of 1990s.
A...
GSK to honor UK's MHRA recommendation on Seroxat
Glaxo-SmithKline Korea said recently that in line with the June 10 recommendation of Medicine and Healthcare Products Regulatory Agency (MHRA) in U.K. that Seroxat (paroxetine) should not be prescribed to young depres...
Pfizer Korea's labour disputes suspended this week.
The labour disputes of Pfizer Korea seems to be stalemated during this week because the top executives officer and other higher working staffs responsible for sales, medical, labor and sales administration took overse...
Kyeongin KFDA was elected 2002 outstanding organization.
The KFDA appraised all affiliate organizations for the purpose of activating a creative and efficient working attitude of all officials through their policy implementing efforts and enthusiasm, and finally decided the...
Pharmaceutical firms feel little threat of hostile M&A
The shareholdings of major shareholders (including special representatives) in domestic listed pharmaceutical firms hovered at 10~30 percent and the majority of owner-chairmen regard their managerial control as stable...
Foreign-invested pharmaceutical firms reiterate making bona fide commitment to outsourcing agreement
Business sources say that there has been an increasing disaccord due to non-fulfillment of the existing distribution agreement incurred by some foreign-invested pharmaceutical firms expressing their strong desire to j...
